Kontiniual-S: What the Collapsed Deal Structure Really Would Have Done to Shareholders
Kontiniual-S's MOU was not a vague promise to inject activity. It combined a reverse split, a minimum public raise, share and warrant issuance, value floors, and an optional seller loan, so the real question was not whether value might enter the shell, but how much of it would actually have reached existing shareholders.
What This Follow-Up Is Isolating
The main article already established that Kontiniual-S's problem is not only finding activity to inject into the shell, but doing so before time and capital-structure pressure box it in. This follow-up isolates the narrower question that matters more for common shareholders: if the June to December 2025 deal path had advanced, what exactly was supposed to enter the shell, and how would that have met the existing shareholder base.
That is the whole point here. The structure disclosed to the market went far beyond a vague MOU. It included a 1:100 reverse split, the injection of an income-producing real-estate asset and Had Asaf shares, a public raise of at least NIS 20 million, a minimum pre-money valuation of NIS 40 million for that raise, share and warrant issuance to the investor, additional warrants to other allottees including the controller, and an optional seller loan of up to NIS 30 million.
That is also where the key analytical gap begins. The figures of NIS 20 million, NIS 30 million, and NIS 40 million could easily create the impression of a transaction with a clear value floor. But those figures did not tell the public what would actually remain after all the new shares, warrants, public capital, and possible seller debt. The term sheet spoke in the language of incoming value and funding. It still did not speak in the language that really decides shareholder outcomes: how much of the enlarged company the old public would keep.
These bars are not additive. Each one represents a separate threshold or funding layer in the disclosed structure.
What the Term Sheet Actually Contained
Once the MOU is broken into its parts, the structure already looks fairly concrete:
| Disclosed element | What was set out | Why it matters |
|---|---|---|
| What was supposed to enter the shell | 100% of a private company owned or controlled by the investor and holding an income-producing real-estate asset, together with Had Asaf shares transferred into the company | This was not a generic "activity injection" headline, but a mix of a real asset and a public security |
| Value floor | The combined value of the real-estate asset and transferred Had Asaf shares could not fall below NIS 30 million, and the real-estate asset itself could not be worth less than NIS 20 million under an external valuation | The structure tried to set a minimum incoming value floor |
| New equity layer | A public offering of at least NIS 20 million at a pre-money company valuation of at least NIS 40 million | The transaction required new outside capital, not only asset injection |
| Possible debt layer | The investor could sell additional Had Asaf shares to the company, beyond the initial package, for up to NIS 30 million in exchange for a seller loan | The incoming package could have arrived together with a new liability layer |
| New capital structure | A 1:100 reverse split, share and unlisted warrant issuance to the investor, and additional unlisted warrants to other allottees including the controller | Existing shareholders were heading into a fully reset cap table |
This is why the transaction cannot be read as a loose concept note. It already had real figures, value thresholds, a financing leg, and a defined form of consideration to the investor. Precisely for that reason, the analysis has to separate two different things: value created on paper, and value that would actually have remained accessible to legacy shareholders.
Where Value Was Created, and Where It Was Not Yet Promised to Shareholders
The MOU did give the market enough to say the transaction was not empty. It required an external valuation of at least NIS 20 million for the real estate, a minimum combined transferred package of NIS 30 million, and a minimum public raise of NIS 20 million. In other words, the ambition was to build a larger, better financed platform than an empty shell.
But once the analysis moves to shareholder economics, the disclosure becomes far thinner. The published term-sheet summary did not include an exchange ratio. It did not include the warrant terms for the investor. It did not include the warrant terms for the other allottees. It also did not disclose what portion of the enlarged company would remain with existing shareholders. Even the seller-loan terms were left for the detailed agreement.
| Layer | What it creates | What it does not guarantee to existing shareholders |
|---|---|---|
| 1:100 reverse split | A structural reset of the shell ahead of a larger transaction | A reverse split does not create economic value by itself |
| Injection of the real-estate asset and Had Asaf shares | Clear incoming assets and a larger public vehicle | It does not say what share of that value the old public would still own |
| Raise of at least NIS 20 million | New cash and transaction funding | The raise itself adds new shareholders and another dilution layer |
| Warrants to the investor and other allottees | A compensation and incentive tool inside the transaction | Exercise terms and quantity were not disclosed, so the eventual dilution could not be calculated |
| Optional seller loan of up to NIS 30 million | Additional financing capacity beyond the public raise | It is a possible liability, not clean equity value for common shareholders |
This is the line the market needed to read correctly. The NIS 40 million floor was attached to the public raise, not to a retained ownership floor for the legacy float. In other words, the public got a frame for transaction size and funding, but not a formula for what share of the new company would still belong to those already there.
So even without a precise dilution model, the direction is clear. If the deal had closed, existing shareholders would not simply have received "an asset coming into the shell." They would have entered a much larger structure of new shares, warrants, public capital, and possibly seller debt. Value might have gone up, but the route to that value ran through a material expansion of the cap table and through an added financing layer.
This Was a Full Shell Remaking, Not a Small Add-On
Another easy mistake is to read the structure as little more than an asset injection plus a raise. The conditions tell a deeper story. Completion depended, among other things, on approvals from the company, the investor-owned private company, and the asset company, as well as on receiving the required approvals from the Israel Securities Authority, the stock exchange, the tax authority, and banks if needed. The company also had to satisfy exchange rules for returning its securities to the main list, and there could be no legal obstacle to completion.
And that still was not all. At closing, directors requested by the investor were supposed to be appointed, while all current officeholders other than the external directors were supposed to step down. The relevant corporate bodies also needed to approve compensation for officeholders after the merger, and the company had to put in place a seven-year Run Off D&O policy with coverage of $5 million for the officeholders serving immediately before completion.
There was another layer that makes clear how preliminary the structure still was. The MOU said explicitly that additional conditions precedent might still be required, and that some of the listed conditions could still be updated in the detailed agreement. So even the framework already published to the market was not yet final in either its legal engineering or its cap-table engineering.
The important point is that the disclosed structure did not describe only an asset deal. It described an almost complete replacement of the public shell itself: new capital, new management, a new board, regulatory approvals, Run Off insurance, and a public raise that still had to be completed. That is why shareholder value could never have been judged solely through the quality of the incoming real estate and Had Asaf shares. It also had to be judged through the equity price, financing burden, and governance reset attached to the whole package.
Why the December Termination Changes the Read
In its 18 December 2025 notice, the company said explicitly that the parties had not reached a detailed agreement within the timetable set in the MOU, despite the fact that the MOU had been extended from time to time. The company said it did not intend to extend the MOU again, and for the avoidance of doubt also stated that negotiations regarding the proposed transaction had ended as of that notice.
That collapse matters more than "another deal that did not close." The clauses that would actually have determined shareholder economics, the exchange ratio, the warrant terms, the seller-loan terms, and the post-closing control split, never reached the stage of a binding detailed agreement. So what failed in December was not a guaranteed valuation. It was the only framework the market ever saw that could begin to measure the tradeoff between incoming value and the dilution, financing, and control reset required to get there.
This also explains why the NIS 30 million and NIS 40 million figures could be misleading if read too quickly. They were not net shareholder value. They were building blocks inside a transaction still loaded with conditions, allocations, a public raise, due diligence, and approvals. Once negotiations ended, the only path the market had for testing the economics of the structure disappeared with them.
Conclusion
The core thesis is simple: the collapsed structure was far more serious than an empty MOU, but far less shareholder-friendly than a headline about injecting assets worth tens of millions of shekels could imply. It did set value and funding floors. It did not disclose the one variable that would really have decided the outcome, how much of the enlarged company existing shareholders would still own after all the shares, warrants, and possible seller debt.
So even if the deal had made it to the finish line, the real test would not have been whether value entered the shell. It would have been at what equity and financing price that happened. And because negotiations ended before a detailed agreement was signed, Kontiniual-S was left not only without a deal, but without an answer to the question that matters most for common shareholders: would the incoming value actually have become value they got to keep.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.